ArticleCureus2024
Schwannoma of the Ankle: A Case Report of a Rare Clinical Entity.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A schwannoma is a soft tissue benign tumor that originates from Schwann cells of the peripheral nerve sheath. It is uncommon for it to occur in the foot. The tumor usually has an indolent presentation with a delayed diagnosis that may lead to irreversible nerve damage. The symptoms are related to the compression of the nerve due to the mass effect of the lesion. The authors report a case of a 62-year-old female with a history of breast cancer who was referred to the orthopedics department with pain in the dorsum of the right foot and a positive Tinel sign in the trajectory of the superficial peroneal nerve. The diagnosis of schwannoma of the superficial peroneal nerve was made, and the patient underwent surgery with complete resolution of symptoms. No deficits or recurrences were observed during the two-month follow-up period. The purpose of this report is to draw attention to the high index of suspicion and the need for a correct diagnosis for optimal clinical results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.